Walleye Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.09M Sell
8,800
-4,100
-32% -$4.16M 0.03% 508
2025
Q4
$13.9M Sell
12,900
-17,100
-57% -$16.4M 0.04% 453
2025
Q3
$22.9M Buy
30,000
+3,900
+15% +$2.9M 0.09% 213
2025
Q2
$20.3M Buy
26,100
+5,000
+24% +$3.89M 0.08% 225
2025
Q1
$17.4M Sell
21,100
-49,400
-70% -$41.1M 0.08% 240
2024
Q4
$54.4M Sell
70,500
-2,700
-4% -$2.24M 0.13% 99
2024
Q3
$64.9M Sell
73,200
-4,800
-6% -$4.32M 0.13% 82
2024
Q2
$70.6M Sell
78,000
-17,900
-19% -$14.3M 0.13% 84
2024
Q1
$74.6M Buy
95,900
+16,500
+21% +$11.7M 0.13% 85
2023
Q4
$46.3M Sell
79,400
-2,900
-4% -$1.69M 0.1% 117
2023
Q3
$44.2M Buy
82,300
+33,700
+69% +$17.4M 0.11% 94
2023
Q2
$22.8M Buy
48,600
+45,200
+1,329% +$19M 0.08% 135
2023
Q1
$1.17M Sell
3,400
-4,500
-57% -$1.52M 0.02% 1051
2022
Q4
$2.89M Sell
7,900
-2,800
-26% -$993K 0.05% 428
2022
Q3
$3.46M Buy
+10,700
New +$3.39M 0.07% 317
2020
Q2
Sell
-2,400
Closed -$333K 810
2020
Q1
$333K Sell
2,400
-3,700
-61% -$508K 0.07% 314
2019
Q4
$802K Sell
6,100
-5,200
-46% -$603K 0.05% 492
2019
Q3
$1.26M Sell
11,300
-1,000
-8% -$111K 0.08% 362
2019
Q2
$1.36M Buy
12,300
+1,600
+15% +$188K 0.15% 180
2019
Q1
$1.39M Buy
+10,700
New +$1.3M 0.23% 96

Other funds holding LLY

Walleye Capital's LLY Position: Q1 2026 in Review

Walleye Capital reduced its Eli Lilly (LLY) stake by 43% in Q1 2026, selling an estimated $15.7M and leaving 20,644 shares worth $19M. The position accounts for 0.08% of the portfolio, ranked #210.

Walleye Capital first reported a position in LLY in Q1 2019 and has held it in 22 quarters since. The position peaked at $47M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Walleye Capital held 20,644 shares of Eli Lilly worth $19M as of Q1 2026.
  • Walleye Capital sold 15,497 Eli Lilly shares in Q1 2026, an estimated $15.7M.
  • Eli Lilly made up 0.08% of Walleye Capital's portfolio in Q1 2026, its #210 holding.
  • Walleye Capital first reported a position in Eli Lilly in Q1 2019 and has held it in 22 quarters since.
  • Walleye Capital's Eli Lilly position peaked at $47M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.